Gb. Makara et J. Haller, Non-genomic effects of glucocorticoids in the neural system - Evidence, mechanisms and implications, PROG NEUROB, 65(4), 2001, pp. 367-390
Complementing the classical concept of genomic steroid actions, here we (i)
review evidence showing that important neural effects of glucocorticoids a
re exerted by non-genomic mechanisms; (ii) describe known mechanisms that m
ay underlie such effects; (iii) summarize the functions and implications of
non-genomic mechanisms and (iv) outline future directions of research. The
role of non-genomic mechanisms is to shape the response of the organism to
challenges that require a substantial reorganization of neural and somatic
functions and involve massive behavioral shifts. Non-genomic effects may (
i) prepare the cell for subsequent glucocorticoid-induced genomic changes,
(ii) bridge the gap between the early need of change and the delay in the e
xpression of genomic effects and (iii) may induce specific changes that in
some instances are opposite to those induced by genomic mechanisms. The lat
ter can be explained by the fact that challenging situations require differ
ent responses in early (acute) and later (chronic) phases. Data show that n
on-genomic mechanisms of glucocorticoid action play a role in both patholog
ical phenomena and the expression of ameliorative pharmacological effects.
Non-genomic mechanisms that underlie many glucocorticoid-induced neural cha
nges constitute a for long overlooked controlling factor. Despite the multi
tude and the variety of accumulated data, important questions remain to be
answered. (C) 2001 Published by Elsevier Science Ltd.